Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam combined with alfentanil for sedation in painless hysteroscopy
ChiCTR2300071424Phase 4Recruiting
- Sponsor
- Nanhua Hospital affiliated to Nanhua University
- Start
- May 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of remimazolam, alfentanil and propofol in None (5 arms), sponsored by Nanhua Hospital affiliated to Nanhua University. Primary endpoints: Mean arterial pressure, Heart rate and 2 more. Started May 2023; status: recruiting.
02
Drugs
remimazolamalfentanilpropofol
Beyond the preview
Go deeper on ChiCTR2300071424.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300071424.